Shares of Transenterix Inc (NASDAQ:TRXC) shot up 8% on Monday . The stock traded as high as $1.14 and last traded at $1.21. 2,079,179 shares traded hands during mid-day trading, an increase of 87% from the average session volume of 1,110,970 shares. The stock had previously closed at $1.12.
Several research firms recently weighed in on TRXC. B. Riley cut shares of Transenterix to a “neutral” rating and set a $0.70 price target on the stock. in a report on Tuesday, May 16th. Zacks Investment Research lowered Transenterix from a “buy” rating to a “sell” rating in a research report on Tuesday, August 8th.
The company’s 50-day moving average is $0.79 and its 200 day moving average is $0.83. The stock’s market capitalization is $187.16 million.
Several hedge funds and other institutional investors have recently modified their holdings of TRXC. Global X Management Co. LLC lifted its stake in shares of Transenterix by 238.3% during the 2nd quarter. Global X Management Co. LLC now owns 331,075 shares of the company’s stock worth $235,000 after purchasing an additional 233,213 shares during the last quarter. LMR Partners LLP purchased a new stake in shares of Transenterix during the 2nd quarter worth $189,000. UBS Oconnor LLC purchased a new stake in shares of Transenterix during the 2nd quarter worth $390,000. Goldman Sachs Group Inc. lifted its stake in shares of Transenterix by 7,137.7% during the 2nd quarter. Goldman Sachs Group Inc. now owns 1,203,199 shares of the company’s stock worth $854,000 after purchasing an additional 1,186,575 shares during the last quarter. Finally, Royal Bank of Canada lifted its stake in shares of Transenterix by 17.1% during the 2nd quarter. Royal Bank of Canada now owns 418,867 shares of the company’s stock worth $298,000 after purchasing an additional 61,034 shares during the last quarter.
COPYRIGHT VIOLATION NOTICE: “Transenterix Inc (TRXC) Shares Up 8%” was first published by Ticker Report and is the property of of Ticker Report. If you are viewing this piece on another domain, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The original version of this piece can be accessed at https://www.tickerreport.com/banking-finance/2887729/transenterix-inc-trxc-shares-up-8.html.
TransEnterix, Inc is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company’s ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera.
Receive News & Ratings for Transenterix Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transenterix Inc and related companies with MarketBeat.com's FREE daily email newsletter.